105 related articles for article (PubMed ID: 9781646)
21. Expression of cytoskeletal components in melanocytic skin lesions. An immunohistochemical study.
Puches R; Smolle J; Rieger E; Soyer HP; Kerl H
Am J Dermatopathol; 1991 Apr; 13(2):137-44. PubMed ID: 2029088
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic and prognostic role of galectin 3 expression in cutaneous melanoma.
Abdou AG; Hammam MA; Farargy SE; Farag AG; El Shafey EN; Farouk S; Elnaidany NF
Am J Dermatopathol; 2010 Dec; 32(8):809-14. PubMed ID: 20885286
[TBL] [Abstract][Full Text] [Related]
23. Enhanced expression of Ki-67, topoisomerase IIalpha, PCNA, p53 and p21WAF1/Cip1 reflecting proliferation and repair activity in UV-irradiated melanocytic nevi.
Rudolph P; Tronnier M; Menzel R; Möller M; Parwaresch R
Hum Pathol; 1998 Dec; 29(12):1480-7. PubMed ID: 9865836
[TBL] [Abstract][Full Text] [Related]
24. The proliferation marker pKi-67 organizes the nucleolus during the cell cycle depending on Ran and cyclin B.
Schmidt MHH; Broll R; Bruch HP; Bögler O; Duchrow M
J Pathol; 2003 Jan; 199(1):18-27. PubMed ID: 12474222
[TBL] [Abstract][Full Text] [Related]
25. Reticulin and NM23 staining in the interpretation of lymph nodal nevus rests.
Kanner WA; Barry CI; Smart CN; Frishberg DP; Binder SW; Wick MR
Am J Dermatopathol; 2013 Jun; 35(4):452-7. PubMed ID: 23694823
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of epidermal growth factor receptor in melanocytic tumours demonstrated by immunohistochemistry and mRNA in situ hybridization.
Sparrow LE; Heenan PJ
Australas J Dermatol; 1999 Feb; 40(1):19-24. PubMed ID: 10098284
[TBL] [Abstract][Full Text] [Related]
27. A single fission yeast mitotic cyclin B p34cdc2 kinase promotes both S-phase and mitosis in the absence of G1 cyclins.
Fisher DL; Nurse P
EMBO J; 1996 Feb; 15(4):850-60. PubMed ID: 8631306
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical detection of CDK4 and p16INK4 proteins in cutaneous malignant melanoma.
Wang YL; Uhara H; Yamazaki Y; Nikaido T; Saida T
Br J Dermatol; 1996 Feb; 134(2):269-75. PubMed ID: 8746340
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas.
Kanavaros P; Bai M; Stefanaki K; Poussias G; Rontogianni D; Zioga E; Gorgoulis V; Agnantis NJ
Histol Histopathol; 2001 Apr; 16(2):377-86. PubMed ID: 11332692
[TBL] [Abstract][Full Text] [Related]
30. Method of melanin bleaching in MIB1-Ki67 immunostaining of pigmented lesions: A quantitative evaluation in malignant melanomas.
Li LX; Crotty KA; Kril JJ; Palmer AA; McCarthy SW
Histochem J; 1999 Apr; 31(4):237-40. PubMed ID: 10447065
[TBL] [Abstract][Full Text] [Related]
31. Proliferative activities in Spitz nevus compared with melanocytic nevus and malignant melanoma using expression of PCNA/cyclin and mitotic rate.
Tu P; Miyauchi S; Miki Y
Am J Dermatopathol; 1993 Aug; 15(4):311-4. PubMed ID: 8105711
[TBL] [Abstract][Full Text] [Related]
32. Aberrant expression of cyclin A and cyclin B1 proteins in oral carcinoma.
Kushner J; Bradley G; Young B; Jordan RC
J Oral Pathol Med; 1999 Feb; 28(2):77-81. PubMed ID: 9950254
[TBL] [Abstract][Full Text] [Related]
33. Role of ROC1 protein in the control of cyclin D1 protein expression in skin melanomas.
Nai G; Marques M
Pathol Res Pract; 2011 Mar; 207(3):174-81. PubMed ID: 21300445
[TBL] [Abstract][Full Text] [Related]
34. The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.
Kallakury BV; Sheehan CE; Ambros RA; Fisher HA; Kaufman RP; Ross JS
Cancer; 1997 Aug; 80(4):753-63. PubMed ID: 9264360
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
Simonetti O; Lucarini G; Brancorsini D; Nita P; Bernardini ML; Biagini G; Offidani A
Cancer; 2002 Nov; 95(9):1963-70. PubMed ID: 12404291
[TBL] [Abstract][Full Text] [Related]
36. Ki 67 immunostaining in melanocytic skin tumors. Correlation with histologic parameters.
Soyer HP
J Cutan Pathol; 1991 Aug; 18(4):264-72. PubMed ID: 1719049
[TBL] [Abstract][Full Text] [Related]
37. Mitotically active proliferative nodule arising in a giant congenital melanocytic nevus: a diagnostic pitfall.
Nguyen TL; Theos A; Kelly DR; Busam K; Andea AA
Am J Dermatopathol; 2013 Feb; 35(1):e16-21. PubMed ID: 23348144
[TBL] [Abstract][Full Text] [Related]
38. Levels of cyclin D1 and D3 in malignant melanoma: deregulated cyclin D3 expression is associated with poor clinical outcome in superficial melanoma.
Flørenes VA; Faye RS; Maelandsmo GM; Nesland JM; Holm R
Clin Cancer Res; 2000 Sep; 6(9):3614-20. PubMed ID: 10999753
[TBL] [Abstract][Full Text] [Related]
39. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
40. The initial steps of tumor progression in melanocytic lineage: a histochemical approach.
Wollina U; Kilian U; Henkel U; Schaarschmidt H; Knopf B
Anticancer Res; 1991; 11(4):1405-14. PubMed ID: 1746897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]